AUDIOCONFERENCE ON TAPE
sponsored by The Credentialing Resource Center
presented on December 6, 2005
A revolutionary surgical procedure . . . a new technology advancement . . . better ways to care for your patients are being developed as we speak.
As professionals dedicated to improving the art of medicine, these advancements are exciting but you know all too well challenges and obstacles you're up against as you consider the implementation process.
From the authority on medical staff credentialing and privileging!
As a nationally respected leader with renowed expertise in credentialing and privileging, The Greeley Company's educational services have helped thousands of healthcare professionals solve some of the toughest problems you face.
"The quality of the services received from The Greeley Company is remarkable . . . their services reflect a symbol of excellence."
New audioconference series helps you assess new procedures and technology
The Greeley Company is excited to bring you the New Procedures and Technologies audioconference series. Devoted to the examination of new, different, or controversial procedures and technologies, each audioconference features an expert panel discussion and case studies to help you weigh all the requirements you must consider to implement and perform such procedures in your facility.
The first audioconference in the series delves deep into issues surrounding Carotid Artery Stenting.
Join us and learn from expert speakers:
Hugh Greeley
Founder of The Greeley Company, Marblehead, MA
Rodney Raabe, MD
Director of Radiology, Sacred Heart Medical Center, Spokane, WA
Philip Hinton, MD
Independent Consultant, MD Professional Corporation, and the former CEO of Community Medical Centers, Fresno, CA
About hot topics that include:
- Essential questions a hospital must answer with regard to assessing any innovation/new technology
- How to process any privileging request for a new or emerging technology
- Regulatory guidelines for granting privileges for new technology
- Why so many hospitals are receiving privileging requests to perform carotid stenting procedures
- Determining qualifications needed to grant privileges for carotid stenting
- The five "P's" for hospitals that don't have a policy
- A 30-minute Q&A session
All your colleagues can listen for ONE LOW PRICE!
Your purchase allows for an unlimited number of listeners!
Plus, it includes a follow-along materials packet—make a copy for all of your peers!
INTENDED AUDIENCE:
- Medical staff professionals
- Department chairs
- VPMA
- Medical executive committee
- CEO
- COO
- VP strategic/business/service line development
- Risk Managers
COMPLETE PROGRAM AGENDA
- Five "Ps"
- Process any privileging requests for new or emerging technology: Determine if your institution will even permit anyone to do the procedure or use the technology
- Introduction to Innovations package material (explain Deming Management Method)
- Eleven questions a hospital must answer with regard to assessing any innovation/new technology
- Materials needed/costs
- Method of production
- New hires needed
- Changes in equipment
- New-skill training needed
- Methods of training
- Supervisory training
- Cost of production
- Cost/methods of marketing the service
- How used by customers
- Customer satisfaction
- Four additional questions specific to healthcare setting
- Innovation is approved for clinical use (FDA), but is it better than existing interventions?
- What departments affected, and what are their concerns?
- Reimbursement?
- How many physicians will use the technology?
- MD/CEO point of view on importance of using systematic way to process requests to use new technology
- Clinical aspect; lack of policies because technology is so new
- Reviewing requests for new technology: What would Deming say?
- Regulatory guidelines for granting privileges for any new technology
- JCAHO regulations (patient safety, etc.)
- CMS regulations (reimbursement and patient safety)
- Hospital's own quality assurance program
- National data for comparison
- Handling Requests to perform Carotid Stent Procedures
- Background
- Why so many hospitals are receiving privileging requests to perform carotid stenting procedures
- FDA approved the devices
- Better success rate than carotid endartertomy
- Costs
- Profits for hospital
- Implications for length of stay
- Risks
- Reimbursement
- Turf Battle Issues
- Different specialties have different training criteria/experience; how to deal with the political issues
- Need for policy on dispute resolution
ABOUT THE SPEAKERS
Hugh Greeley is founder of The Greeley Company and has participated as a faculty member in over 2,500 seminars on the subjects of medical staff organization, quality improvement, credentialing, trustee responsibility, antitrust, accreditation, and other related subjects.
Rodney D. Raabe, MD, is the executive council for SIR (for 6 years). He has co-chaired the SIR / ASITN National Carotid STENT task force committee and started a National Screening Program for Peripheral arterial disease called "Legs for Life" (sponsored by SIR). Dr. Raabe is a investigator on multiple carotid stent research studies, as well as many other different types of research areas. He is also a trainer for Guidant and Cordis for physicians to learn carotid stenting.
Dr. Philip Hinton is a board certified surgeon, who practiced vascular surgery in Fresno, California for 22 years. Dr. Hinton has also served as president and CEO of Community Medical Centers in Fresno, CA from 1996 to 2005. As CEO, he grew Community from a 2 hospital 550-bed system to a 4-hospital 890-bed system with $680 million annual revenues and 6200 employees. Two of his four hospitals achieved PEP-C III top "3 star" rating for patient satisfaction in 2004.
PROGRAM MATERIALS:
Program materials will be provided with PDF links.
Save money when you purchase multiple copies! Ask your customer service representative about money-saving
discounts and bulk orders. Call toll free 800-650-6787 or e-mail
customerservice@hcpro.com.
